Living with Leukemia

Chapter 1: You Just Heard the Word Leukemia. Start Here.

Somebody said the word out loud, maybe a doctor on the phone, maybe a nurse reading from a chart, and now it is sitting in the room with you. Leukemia. It is a strange, heavy word, and the first thing worth knowing is that it does not point to one disease. It points to a family of four.

Leukemia is a cancer of the blood and bone marrow, the soft tissue inside your larger bones where new blood cells are made. In a healthy body, that marrow runs like a factory around the clock, sending out red cells, white cells, and platelets on schedule. In leukemia, something goes wrong in the assembly line: abnormal white blood cells multiply without stopping and crowd out the normal workers. Chapter 2 walks through exactly what that crowding does to your body and why it produces the tiredness, infections, and bruising so many patients notice. This chapter's job is narrower: to help you understand what kind of leukemia diagnosis you are actually holding, and to hand you a map for the rest of the book.

Four Diseases, One Name

Doctors split leukemia along two lines. The first is which type of blood cell went wrong: myeloid cells, which normally become red cells, platelets, and several kinds of infection-fighting white cells, or lymphoid cells, which normally become the white blood cells behind your body's more targeted immune defenses. The second line is speed: acute leukemias move in weeks, chronic leukemias move over months or years, and some are found by accident on a routine blood test long before they cause a single symptom.

Cross those two lines and you get the four main types:

• Acute Lymphoblastic Leukemia (ALL): lymphoid, fast-moving. It is the most common cancer in children, responsible for up to about 80% of pediatric leukemia cases, though adults get it too.
• Acute Myeloid Leukemia (AML): myeloid, fast-moving. More common in adults over 60.
• Chronic Lymphocytic Leukemia (CLL): lymphoid, slow-moving. Also mostly a disease of older adults, often caught on a blood test done for an unrelated reason.
• Chronic Myeloid Leukemia (CML): myeloid, slow-moving. Defined by a specific genetic change called the Philadelphia chromosome, which Chapter 4 explains in full.

If you already know which letters apply to you, Chapter 3 goes much deeper: the subtypes within each category, what your pathology report's numbers mean, and the staging systems doctors use, including Rai and Binet staging for CLL and the three phases of CML. If you do not know yet, that is normal too. Many people get the word "leukemia" before they get the full letter combination, sometimes by days.

How Common Is This, Really

Roughly 61,090 people in the United States are told they have some form of leukemia each year, according to national cancer registry data. That makes it about the 10th most common cancer overall, a large enough number that oncology teams across the country diagnose and treat it constantly. You are not walking into unfamiliar territory for your medical team, even if it feels entirely unfamiliar to you.

Here is a number worth sitting with for a moment. Since 2006, leukemia incidence in the US has ticked up slightly, about 0.6% a year. Over that same period, mortality has dropped by roughly 1.5% a year. More people are being diagnosed, and fewer of them are dying from it. That gap between the two lines on the graph is not an accident or a statistical fluke. It is what two decades of new drugs, better genetic testing, and refined transplant techniques look like when you add them up.

Take CML as one example of what changed. Before targeted drugs called tyrosine kinase inhibitors arrived, a CML diagnosis was frequently fatal within a few years. Now many people manage it for decades with a daily pill, monitored by regular blood tests. CLL has moved through a similar shift more recently: national treatment guidelines updated for 2026 now favor targeted pill-based therapies as the first choice for most patients, with the older chemo-and-antibody combinations reserved for a smaller group of cases. Chapter 8 lays out these treatment classes in detail, including how CAR T-cell therapy, which reprograms a patient's own immune cells to hunt leukemia cells, has expanded into new uses for both ALL and CLL.

What This Book Does for You

Think of the chapters ahead as answering the questions in roughly the order they show up after a diagnosis like this.

Two spots on that map are worth knowing about right now. Chapter 6 is a single, complete list of warning signs that mean you should call your emergency number or get to an ER without delay: things like uncontrolled bleeding, a high fever with chills, or sudden confusion. It exists as one dedicated chapter precisely so you never have to hunt for it across several sections during a scary moment. Chapter 7 does something similar for your next appointment: a full list of questions worth bringing to the doctor once your specific type and subtype are confirmed, so you are not trying to think of them in the exam room.

Everything between those two anchor points, the biology of your blood counts, the reasons this happened, the tests that confirmed it, the treatments now available, and how to actually get through the weeks and months of care, is covered in its own dedicated chapter, in the order you are likely to need it.

Right now, though, there is a more immediate question sitting underneath the name of your disease: what is actually happening inside your bloodstream that is making you feel the way you feel. That is where the next chapter picks up.

End of free sample. The full book picks up right where this leaves off.